Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate.
about
Functional anatomy of movement disordersBasal ganglia activity patterns in parkinsonism and computational modeling of their downstream effectsThe adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted ratHigh frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats.NMDA receptors in the basal ganglia.Remacemide: current status and clinical applications.Dyskinesias induced by subthalamotomy in Parkinson's disease are unresponsive to amantadine.Activation of presynaptic kainate receptors suppresses GABAergic synaptic transmission in the rat globus pallidus.Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's DiseaseParkinsonism-related features of neuronal discharge in primates.Disrupting neuronal transmission: mechanism of DBS?A tale on animal models of Parkinson's disease.Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's disease.Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models.Neurochemical mechanisms induced by high frequency stimulation of the subthalamic nucleus: increase of extracellular striatal glutamate and GABA in normal and hemiparkinsonian rats.The modulation of calcium current by GABA metabotropic receptors in a sub-population of pallidal neurons.Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson's disease.Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol.Motor manifestations and basal ganglia output activity: the paradox continues.Tremor arrest with thalamic microinjections of muscimol in patients with essential tremor.The non-NMDA glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline, but not NMDA antagonists, block the intrastriatal neurotoxic effect of MPP+.Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia.Turning behavior induced by injections of glutamate receptor antagonists into the substantia nigra of the rat.
P2860
Q24544908-20FEB5DC-89E8-4E91-BC96-ED51F0558AC5Q28271277-479A360F-A6D3-4E86-A1C8-60B7B6692EF2Q28343807-EE3A9C62-C566-4934-BE20-5AA2F678E746Q32001490-088D6B2C-3DD2-46A9-881E-151093AB0A62Q33989361-FBD70A17-ACD2-4EAB-B3B3-E97267AE96DAQ34074824-4833B7AB-CD27-4B58-848A-662BE5C1B930Q36142469-02C1F7BA-F8FA-4317-BF54-D89BD6B2AB73Q36328049-76E7754E-D4C1-488B-A2C8-749B72B6CE25Q36674371-E29BB80D-3A18-41D5-BC2A-4F7C04409314Q37094093-7A3C87BA-7B88-4B6B-8839-32C3543F4ED9Q37637283-2EC9FE9A-FC4D-4F3E-80CC-0CC78BF26A35Q37882583-AB303090-0C79-488B-8773-E06AE7717934Q38063779-DC23B2CE-FFFF-433F-9A05-A50B7CD8CA98Q41584434-B84F164E-CA77-4783-971B-74DE338E68F7Q42454736-750A7C3C-23B4-43C8-B32F-D8D5F57EE984Q42480718-F67CE7AE-6428-4D68-B06D-E9C4D7A16982Q43507658-2EC38BC7-F08A-43B1-8242-277D660B5E8EQ48089358-FA77EF05-FD07-4915-8381-EE5E65E7C0BFQ48125143-576FD883-D29A-4F02-8890-523760515DFAQ48138867-01E27018-3ACA-469B-A278-DEB9AD43E65FQ48148951-C06ACF02-F8C1-47AF-82A7-C969E65516D0Q48174974-6FD57018-49E0-411E-B01B-84DCA4D4B213Q48906972-3774E336-C105-4870-B463-B43F93B26170
P2860
Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Alleviation of parkinsonism by ...... s pallidus in rat and primate.
@en
type
label
Alleviation of parkinsonism by ...... s pallidus in rat and primate.
@en
prefLabel
Alleviation of parkinsonism by ...... s pallidus in rat and primate.
@en
P2093
P356
P1433
P1476
Alleviation of parkinsonism by ...... s pallidus in rat and primate.
@en
P2093
Brotchie JM
Crossman AR
Mitchell IJ
Sambrook MA
P304
P356
10.1002/MDS.870060208
P407
P577
1991-01-01T00:00:00Z